Rinatry Duo Tablets 2.5/850 mg

Adult dose

This medication is administered twice daily with meals. The dose is determined based on each patient's treatment regimen, efficacy, and tolerability, with a maximum of linagliptin 2.5 mg and metformin 1000 mg not exceeding twice a day. 1. If not previously treated with metformin: Start with this medication at 2.5/500 mg twice daily, taking 1 tablet at a time, and may increase to 2.5/1000 mg, twice daily, taking 1 tablet per dose.

This medication helps control blood sugar levels. However, the use of this medication can rarely lead to serious side effects such as lactic acidosis, which may result in death. This medication should not be used in patients with an allergy to its components or in those with type 1 diabetes, lactic acidosis, or severe renal impairment. Patients in acute conditions such as dehydration, severe infection, or acute myocardial infarction should also exercise caution. When used with other medications that may cause hypoglycemia, there is an increased risk of hypoglycemia, so caution is necessary. Patients with decreased renal function should undergo regular renal function tests, and this medication should not be taken in cases of severe renal impairment. Patients with impaired heart function should periodically monitor heart and kidney function while using this medication, and the intake of this medication should be temporarily stopped before and after surgery or radiological examinations. During treatment with this medication, rare side effects such as pancreatitis or bullous pemphigoid may occur, so if abdominal pain or skin abnormalities occur, consult a doctor immediately. The metformin ingredient may lower vitamin B12 levels, so it is advisable to periodically check vitamin B12 levels during long-term use. Women who are pregnant or may become pregnant, as well as breastfeeding mothers, should not use this medication. It is not recommended for children and adolescents as safety and effectiveness have not been established. Elderly patients commonly have decreased renal function, so appropriate dosing should be determined based on renal function, and regular tests are necessary. In cases of overdose, there may be an increased risk of lactic acidosis, so it is important to strictly adhere to the prescribed dose. This medication should be stored in a sealed container, protected from moisture and direct sunlight, and should not be transferred to another container.

Serious side effects

Urticaria, angioedema, pancreatitis, bullous pemphigoid, lactic acidosis, acute deterioration of renal function, cardiopulmonary disease, sepsis, lactic acidosis due to renal impairment, acute pancreatitis, severe edema, hypertension, pulmonary dysfunction, acute myocardial infarction, shock, severe renal impairment, liver abnormalities (abnormal liver function tests, hepatitis), serious allergic reactions (urticaria, angioedema), severe neurological symptoms (severe and disability-associated arthralgia,

Mild side effects

Hypersensitivity, nasopharyngitis, cough, decreased appetite, diarrhea, constipation, nausea, vomiting, abdominal pain, itching, erythema, rash, oral ulcer formation, taste disorders, decrease in vitamin B12 and deficiency, hypoglycemia, abnormal liver function tests, hepatitis, urticaria, angioedema, bullous pemphigoid, severe and disability-associated arthralgia, rhabdomyolysis, increased lipase, increased amylase, cheilitis, stomatitis, dyspepsia, upper abdominal pain, vomiting

This medication is sensitive to air and moisture, so it should be stored in a sealed container. The recommended storage temperature is between 1 to 30 degrees Celsius at room temperature. This helps maintain the medication's effectiveness for a longer period.

Appearance

Bright orange oval film-coated tablets

Package unit

60 tablets/box [(10 tablets/PTP × 6)]